US Stock MarketDetailed Quotes

AN2 Therapeutics (ANTX)

Watchlist
  • 4.460
  • -0.140-3.04%
Close May 8 16:00 ET
  • 4.450
  • -0.010-0.22%
Post 20:01 ET
160.54MMarket Cap-3.84P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics (ANTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-30.14%38.11M
8.24%9.32M
-14.71%10.04M
-54.56%7.22M
-36.94%11.54M
-21.66%54.55M
-54.25%8.61M
-35.25%11.77M
-4.34%15.88M
14.07%18.3M
Selling and administrative expenses
-5.16%13.34M
-24.08%2.44M
-12.74%3.04M
7.64%4.02M
5.66%3.85M
-4.73%14.07M
-17.61%3.21M
-7.12%3.48M
21.81%3.73M
-10.19%3.64M
-General and administrative expense
-5.16%13.34M
-24.08%2.44M
-12.74%3.04M
7.64%4.02M
5.66%3.85M
-4.73%14.07M
-17.61%3.21M
-7.12%3.48M
21.81%3.73M
-10.19%3.64M
Research and development costs
-38.82%24.77M
27.46%6.88M
-15.53%7M
-73.66%3.2M
-47.53%7.69M
-26.21%40.49M
-63.82%5.4M
-42.57%8.29M
-10.26%12.15M
22.28%14.66M
Operating profit
30.14%-38.11M
-8.24%-9.32M
14.71%-10.04M
54.56%-7.22M
36.94%-11.54M
21.66%-54.55M
54.25%-8.61M
35.25%-11.77M
4.34%-15.88M
-14.07%-18.3M
Net non-operating interest income expense
-46.32%2.93M
-43.77%605K
-45.78%687K
-47.82%754K
-47.08%888K
12.47%5.47M
1.08M
1.27M
1.45M
1.68M
Non-operating interest income
-46.32%2.93M
-43.77%605K
-45.78%687K
-47.82%754K
-47.08%888K
12.47%5.47M
--1.08M
--1.27M
--1.45M
--1.68M
Other net income (expense)
100.04%1K
-5,293.02%-2.23M
100.31%9K
-252.27%-2.24M
81.30%1.45M
-99.86%1K
Special income (charges)
--0
--0
--0
----
----
---2.23M
--9K
---2.24M
----
----
-Less：Restructuring and merger&acquisition
--0
--0
--0
----
----
--2.23M
---9K
--2.24M
----
----
Other non- operating income (expenses)
0.00%1K
----
----
----
----
-97.67%1K
--0
-13.99%1.27M
81.30%1.45M
-99.86%1K
Income before tax
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
Income tax
Net income
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
Net income continuous Operations
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
Minority interest income
Net income attributable to the parent company
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.46%-35.17M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
20.72%-51.32M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
Basic earnings per share
32.56%-1.16
-16.00%-0.29
27.91%-0.31
56.25%-0.21
37.50%-0.35
37.23%-1.72
56.14%-0.25
33.85%-0.43
40.74%-0.48
29.11%-0.56
Diluted earnings per share
32.56%-1.16
-16.00%-0.29
27.91%-0.31
56.25%-0.21
37.50%-0.35
37.23%-1.72
56.14%-0.25
33.85%-0.43
40.74%-0.48
29.11%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -30.14%38.11M8.24%9.32M-14.71%10.04M-54.56%7.22M-36.94%11.54M-21.66%54.55M-54.25%8.61M-35.25%11.77M-4.34%15.88M14.07%18.3M
Selling and administrative expenses -5.16%13.34M-24.08%2.44M-12.74%3.04M7.64%4.02M5.66%3.85M-4.73%14.07M-17.61%3.21M-7.12%3.48M21.81%3.73M-10.19%3.64M
-General and administrative expense -5.16%13.34M-24.08%2.44M-12.74%3.04M7.64%4.02M5.66%3.85M-4.73%14.07M-17.61%3.21M-7.12%3.48M21.81%3.73M-10.19%3.64M
Research and development costs -38.82%24.77M27.46%6.88M-15.53%7M-73.66%3.2M-47.53%7.69M-26.21%40.49M-63.82%5.4M-42.57%8.29M-10.26%12.15M22.28%14.66M
Operating profit 30.14%-38.11M-8.24%-9.32M14.71%-10.04M54.56%-7.22M36.94%-11.54M21.66%-54.55M54.25%-8.61M35.25%-11.77M4.34%-15.88M-14.07%-18.3M
Net non-operating interest income expense -46.32%2.93M-43.77%605K-45.78%687K-47.82%754K-47.08%888K12.47%5.47M1.08M1.27M1.45M1.68M
Non-operating interest income -46.32%2.93M-43.77%605K-45.78%687K-47.82%754K-47.08%888K12.47%5.47M--1.08M--1.27M--1.45M--1.68M
Other net income (expense) 100.04%1K-5,293.02%-2.23M100.31%9K-252.27%-2.24M81.30%1.45M-99.86%1K
Special income (charges) --0--0--0-----------2.23M--9K---2.24M--------
-Less：Restructuring and merger&acquisition --0--0--0----------2.23M---9K--2.24M--------
Other non- operating income (expenses) 0.00%1K-----------------97.67%1K--0-13.99%1.27M81.30%1.45M-99.86%1K
Income before tax 31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M-8.44%-16.62M
Income tax
Net income 31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M-8.44%-16.62M
Net income continuous Operations 31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M-8.44%-16.62M
Minority interest income
Net income attributable to the parent company 31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M-8.44%-16.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.46%-35.17M-15.79%-8.71M26.63%-9.35M55.23%-6.46M35.92%-10.65M20.72%-51.32M55.49%-7.52M23.70%-12.75M8.66%-14.44M-8.44%-16.62M
Basic earnings per share 32.56%-1.16-16.00%-0.2927.91%-0.3156.25%-0.2137.50%-0.3537.23%-1.7256.14%-0.2533.85%-0.4340.74%-0.4829.11%-0.56
Diluted earnings per share 32.56%-1.16-16.00%-0.2927.91%-0.3156.25%-0.2137.50%-0.3537.23%-1.7256.14%-0.2533.85%-0.4340.74%-0.4829.11%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -